Lenvatinib for the treatment of radio-iodine refractory thyroid cancer in real-life practice. Berdelou, A.; Borget, I.; Godbert, Y.; Nguyen, T.; Garcia, M. E.; Chougnet, C. N.; Ferru, A.; Buffet, C.; Chabre, O.; Huillard, O.; Leboulleux, S.; Schlumberger, M.. Thyroid. 2017; : . doi:10.1089/thy.2017.0205Article
Oncostat